Insider Transactions in Q4 2020 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2020
|
Mansoor Raza Mirza |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$90,000
$18.0 P/Share
|
|
Dec 18
2020
|
Mansoor Raza Mirza |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$25,000
$5.43 P/Share
|
|
Dec 07
2020
|
Mansoor Raza Mirza |
SELL
Open market or private sale
|
Direct |
20,000
-52.08%
|
$320,000
$16.07 P/Share
|
|
Dec 07
2020
|
Mansoor Raza Mirza |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$100,000
$5.43 P/Share
|
|
Dec 01
2020
|
Christopher Brett Primiano EVP, CBO, GC & Secretary |
SELL
Open market or private sale
|
Direct |
137,061
-93.7%
|
$2,330,037
$17.51 P/Share
|
|
Dec 01
2020
|
Christopher Brett Primiano EVP, CBO, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
137,061
+48.37%
|
$1,370,610
$10.42 P/Share
|
|
Nov 02
2020
|
Christopher Brett Primiano EVP, CBO, GC & Secretary |
SELL
Open market or private sale
|
Direct |
772
-14.58%
|
$10,808
$14.92 P/Share
|
|
Oct 30
2020
|
Tanya Lewis EVP, Chief Reg. Affairs |
SELL
Open market or private sale
|
Direct |
226
-29.54%
|
$3,390
$15.58 P/Share
|
|
Oct 28
2020
|
Tanya Lewis EVP, Chief Reg. Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
765
+50.0%
|
-
|
|
Oct 13
2020
|
Christopher Brett Primiano EVP, CBO, GC & Secretary |
SELL
Open market or private sale
|
Direct |
39,271
-51.33%
|
$667,607
$17.03 P/Share
|
|
Oct 13
2020
|
Christopher Brett Primiano EVP, CBO, GC & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
39,271
+29.5%
|
$353,439
$9.8 P/Share
|
|
Oct 12
2020
|
Sharon Shacham Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,500
-0.98%
|
$105,000
$14.89 P/Share
|
|
Oct 12
2020
|
Sharon Shacham Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.49%
|
$0
$0.03 P/Share
|
|
Oct 12
2020
|
Michael Kauffman Director |
SELL
Open market or private sale
|
Indirect |
7,500
-0.98%
|
$105,000
$14.89 P/Share
|
|
Oct 12
2020
|
Michael Kauffman Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
7,500
+0.49%
|
$0
$0.03 P/Share
|